Katherina Sewald

10PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersInfectious agentsMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 20, 2025
Telomerase modRNA Offers a Novel RNA-Based Approach to Treat Human Pulmonary Fibrosis.

Jia Li Ye, Klaudia Grieger, Dongchao Lu

|Mar 12, 2025
AMPK Activation Downregulates TXNIP, Rab5, and Rab7 Within Minutes, Thereby Inhibiting the Endocytosis-Mediated Entry of Human Pathogenic Viruses.

Viktoria Diesendorf, Veronica La Rocca, Michelle Teutsch

|Dec 10, 2024
Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept.

Miriam Alb, Kristin Reiche, Michael Rade

|Dec 10, 2024
An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system.

Vanessa Neuhaus, Laure-Alix Clerbaux, Katherina Sewald

|Dec 10, 2024
Analyzing IL-2-induced vascular leakage with an irAOP as tool.

Patricia Gogesch, Samira Ortega Iannazzo, Tamara Zimmermann

|Dec 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways.

Alexander Mazein, Muhammad Shoaib, Miriam Alb

Pageof 2

Frequent Collaborators

3 joint publications

Jochen Bodem

3 joint publications

Vanessa Neuhaus

2 joint publications

Nina Geiger

2 joint publications

Samira Ortega Iannazzo